30 high-value jobs are expected this year across quality, regulatory, supply chain, finance, and support functions, following the announcement of a multimillion euro investment at Cork Airport Business Park.
Cork City’s strategic business gateway, has announced that it will host the European headquarters of Evumed, a forward-thinking generic and biopharmaceutical company committed to advancing healthcare across Europe. These investments will serve to further the company’s mission of advancing healthcare by ensuring continuity of supply and enabling patients across Europe to access high-quality, affordable medications.
The deal was completed by letting agents Knight Frank, who are also in discussion with three global companies regarding potential tenancies at the site.
This latest investment highlights the business park’s central role in supporting the city’s growth through its ability to generate high-value jobs, attract international talent, and contribute significantly to Cork’s financial and social infrastructure.
Colm Moynihan, president of Evumed said that Cork Airport Business Park’s exceptional global connectivity and modern infrastructure, coupled with Cork’s position as a global hub for pharmaceutical manufacturing and innovation offers Evumed ‘the ideal location to grow as we aim to develop and deliver generic, branded, and biologic medicines and bring innovation and accessibility together to improve lives.’
This development comes shortly after Cork Airport Business Park celebrated its 25th year as the gateway to business in the south of Ireland in 2025, with Evumed’s headquarters located alongside globally recognised names such as Amazon, IBM, McKesson, Emerson, Aviva, GSK, Statkraft and Red Hat.
